Thrombus and Inflammation Study in Sudden Cardiac DEath
TIDE
Thrombus and Inflammation in Sudden Cardiac DEath
1 other identifier
interventional
380
1 country
1
Brief Summary
Sudden death is a natural death occurring within one hour after the onset of symptoms. It remains a major public health problem and accounts for 5 to 10 % of the annual total mortality ie about 300.000 in the United States. Despite community-based interventions, overall survival remains below 5%. Better understanding of the mechanisms causing sudden death could allow early identification of high risk subjects and implementation of specific prevention strategies. The cause of more than 90% of sudden deaths is cardiac with ventricular fibrillation or fast ventricular tachycardia complicating an underlying heart disease. Coronary heart disease and its consequences account for at least 80% of sudden cardiac deaths. Several risk factors associated with sudden death and not with myocardial infarction have been identified in population-based studies. However, the relationship between the occurrence of a coronary artery occlusion and the onset of arrhythmia is unclear. In particular, coronary artery occlusion can be rapidly followed by chest pain, which acts as a signal and allows identification of patients for emergency reperfusion. However, in some cases, the coronary artery occlusion is followed by a sudden onset of arrhythmia and sudden death. Recent data suggest that acute coronary occlusion is caused by plaque erosion or rupture and is followed by an intense local inflammation and rapid thrombus formation. Our hypothesis is that the speed of thrombus formation and coronary occlusion determines the clinical symptoms. Slow and progressive thrombus formation is likely to induce myocardial pre-conditioning thereby reducing the occurrence of ventricular arrhythmia. In contrast, rapid thrombus formation followed by acute coronary artery occlusion and ischemia is more likely to trigger fatal ventricular arrhythmia. During angioplasty procedures, coronary artery thrombus are aspirated, providing the opportunity for pathological studies. The aim of the TIDE study (Thrombus and Inflammation in Sudden Death) is therefore to compare the composition and age of thrombus collected at the site of coronary occlusion in patients with sudden death due to acute coronary artery occlusion and patients with an acute myocardial infarction without ventricular arrhythmia. The following hypothesis will be tested : fresh thrombus is more frequent in patients with sudden cardiac death versus patients with acute myocardial infarction without ventricular arrhythmia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2008
CompletedStudy Start
First participant enrolled
August 1, 2008
CompletedFirst Posted
Study publicly available on registry
September 8, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFebruary 13, 2026
February 1, 2026
3.7 years
July 31, 2008
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Age of thrombus collected at the site of acute coronary occlusion.
one day
Secondary Outcomes (1)
Local and systemic inflammation and endothelial cell apoptosis in patients with sudden death due to acute coronary occlusion, acute myocardial infarction and stable angina treated with coronary angioplasty.
one day
Study Arms (4)
1
EXPERIMENTALSudden cardiac death hospitalized
2
EXPERIMENTALAcute myocardial infarction
3
EXPERIMENTALAngioplasty procedures programmed
4
EXPERIMENTALSudden cardiac death hospitalized without coronary syndrome
Interventions
Eligibility Criteria
You may qualify if:
- Patients with sudden cardiac death without coronary artery occlusion
- Patients with acute myocardial infarction due to coronary artery occlusion
- Patients with stable angina treated with coronary angioplasty
- Written informed consent
- Social security
You may not qualify if:
- Pregnancy
- Small arteries that preclude the use of aspiration devices
- Sudden death without coronary lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Cochin
Paris, 75014, France
Related Publications (1)
Empana JP, Boulanger CM, Tafflet M, Renard JM, Leroyer AS, Varenne O, Prugger C, Silvain J, Tedgui A, Cariou A, Montalescot G, Jouven X, Spaulding C. Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) study. Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):28-36. doi: 10.1177/2048872614538404. Epub 2014 Jun 9.
PMID: 24912925RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xavier JOUVEN, MD
Institut National de la Santé Et de la Recherche Médicale, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2008
First Posted
September 8, 2008
Study Start
August 1, 2008
Primary Completion
April 1, 2012
Study Completion
December 1, 2012
Last Updated
February 13, 2026
Record last verified: 2026-02